New York, NY -- (SBWIRE) -- 05/06/2021 -- Proteomics Market Size – USD 19.37 Billion in 2019, Industry Growth - CAGR of 14.5%, Industry Trends – Advancements in technology.

The global proteomics market is expected to reach a market size of USD 57.57 Billion by 2027 and register a high CAGR during the forecast period, according to a new report by Reports and Data.

The proteomics market is witnessing increased revenue growth due to the growing popularity of personalized medicines, advancements in technology, and rise in research & development expenditure and initiatives. A key driving factor is the rising trend of personalized medicine. Biotechnology and pharmaceutical companies have over the years doubled their investment in R&D of personalized medicine. Advancement in proteomics technologies contributed to the development of personalized medicines by enabling detection of proteomics molecular diagnostics, protein biomarkers, pharmacoproteomics, and protein biochips. Personalized medicine is commonly used in cancer treatment.

Request a Sample Copy of the Research Report @ https://www.reportsanddata.com/sample-enquiry-form/3769

Leading Players Profiled in the Report Include:

Agilent Technologies, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Merck KgaA, PerkinElmer, Inc., Promega Corporation, Waters Corporation, Bruker Corporation, and GE Healthcare.

High cost of proteomics equipment and lack of skilled workforce is a factor hampering growth of the market. However, growth in biomarker identification and advancements in mass spectrometry-based proteomics are expected to provide growth opportunities in the proteomics market. Development of efficient and advanced technologies, rise in genetic and birth disorders, increasing healthcare expenditure, and availability of funds from both public and private sectors will contribute significantly to growth of the market.

The COVID-19 impact:

The COVID-19 pandemic has spurred growth of the proteomics market. Biopharmaceutical companies are investing significantly in research for the development of SARS-COV-2 vaccine. Researchers are identifying drugs for treatments by using separation and identification techniques to examine both new and existing drugs, which is driving growth of the proteomics market.

Further key findings in the report

The reagent segment among the product segments accounted for the largest revenue share in 2019. Increasing research activities and growing need for protein separation from complex mixtures for effective analysis is expected to continue to drive revenue growth of this segment.

Microarray segment dominated other technology segments in terms of revenue share in 2019. Microarray offers label-free detection, full imprint of proteins, and produces vast amounts of information from small samples, which is driving demand for application in biopharmaceutical companies.

The drug discovery segment revenue is expected to continue to register a robust growth rate due to increasing application of proteomics in identification of toxicity and efficacy from biological fluids and target validation and identification. Identification of new drugs by proteomics is one of the major factors supporting market growth.

North America accounted for the largest share in the global proteomics market in 2019. Increasing research activities in healthcare, high funding from governments, and rising need for improved healthcare infrastructure are some key factors driving growth of the market.

Get Attractive Discount @ https://www.reportsanddata.com/discount-enquiry-form/3769

For the purpose of this report, Reports and Data has segmented the global proteomics market on the basis of product, technology, application, and region:

Product Outlook (Revenue, USD Billion; 2017-2027)

Instruments
Reagents
Services

Technology Outlook (Revenue, USD Billion; 2017-2027)

X-Ray Crystallography
Chromatography
Microarray Instruments
Protein Fractionation Systems
Surface Plasma Resonance (SPR) Systems
Electrophoresis
Spectroscopy

Application Outlook (Revenue, USD Billion; 2017-2027)

Clinical Diagnosis
Drug Discovery
Others

Regional Outlook (Revenue, USD Billion; 2017-2027)

North America
U.S
Canada
Europe
Germany
U.K
France
BENELUX
Rest of Europe
Asia Pacific
China
Japan
South Korea
Rest of APAC
MEA
Saudi Arabia
UAE
Rest of MEA
Latin America
Brazil
Rest of LATAM

Request for Customization @ https://www.reportsanddata.com/request-customization-form/3769

Table of contents

Chapter 1.    Market Synopsis

    1.1.    Market Definition

    1.2.    Research Scope & Premise

    1.3.    Methodology

    1.4.    Market Estimation Technique

Chapter 2.    Executive Summary

    2.1.    Summary Snapshot, 2019-2027

Chapter 3.    Indicative Metrics

Chapter 4.    Proteomics Market Segmentation & Impact Analysis

    4.1.    Proteomics Market Material Segmentation Analysis

    4.2.    Industrial Outlook

           4.2.1.    Market indicators analysis

           4.2.2.    Market drivers analysis

                    4.2.2.1.    increasing pharmaceutical and biotechnology R&D expenditure and government funding for proteomics

                    4.2.2.2.    increasing demand for personalized medicine

          4.2.3.    Market restraints analysis

                   4.2.3.1.    High cost of instruments

    4.3.    Technological Insights

    4.4.    Regulatory Framework

    4.5.    ETOP Analysis

    4.6.    Porter's Five Forces Analysis

    4.7.    Competitive Metric Space Analysis

    4.8.    Price trend Analysis

    4.9.    Customer Mapping

    4.10.    Covid-19 Impact Analysis

    4.11.    Global Recession Influence

Continued……..

Have Any Query? Ask Our Experts @ https://www.reportsanddata.com/speak-to-analyst-form/3769

About Reports and Data                              

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.